Skip to content

CDR

Camber expands portfolio

Camber expands portfolio

New launches of Plerixafor Injection, Baclofen Tablets, Fluvoxamine Maleate ER Capsules, and Olmesartan Hydrochlorothiazide Tablets.

A prescription for pharmacy’s comeback

A prescription for pharmacy’s comeback

“Today, retail pharmacies rethinking their pricing structures are exploring a new alternative: cost-based reimbursement models,” the report says. “These models could better align the prices of prescriptions with underlying input costs and the services that pharmacies provide.”